Stock Markets July 31, 2026 07:15 AM

Cohu Shares Jump After Strong Q2 Beat and Upgraded HPC Guidance

Better-than-expected earnings, raised HPC outlook and robust test utilization drive pre-market surge

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
COHU

Cohu's stock spiked in pre-market trading after the semiconductor test equipment maker reported a sizable beat on second-quarter 2026 earnings and revenue, raised its HPC revenue outlook for the year, and issued Q3 guidance implying strong year-over-year growth. Analysts raised price targets and the broader market's positive tone helped lift investor sentiment.

Cohu Shares Jump After Strong Q2 Beat and Upgraded HPC Guidance
COHU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Cohu reported Q2 2026 non-GAAP EPS of $0.26 versus a $0.14 analyst consensus, and revenue of $149 million versus $144 million estimates, a 38% year-over-year increase.
  • Management raised 2026 HPC revenue guidance to $100 million - $110 million and guided Q3 revenue to about $170 million, implying roughly 35% year-over-year growth; the HPC pipeline expanded to about $850 million and test cell utilization reached 80%, supporting recurring revenue of 53% of total sales.
  • Needham increased its price target on Cohu to $65 from $54 and kept a Buy rating; broader market gains in major indices offered a favorable macro backdrop for technology and AI-adjacent stocks.

Cohu saw a sharp pre-market rally of +26.3%, with shares reaching $58.68 after the firm released second-quarter 2026 results that exceeded Wall Street forecasts on both the top and bottom lines. The company reported non-GAAP earnings per share of $0.26 versus an analyst consensus of $0.14, and revenue of $149 million compared with estimates of $144 million. Revenue was up 38% from the comparable quarter a year earlier.

Management provided a more optimistic full-year outlook for its high-performance computing (HPC) business, raising the 2026 HPC revenue range to $100 million - $110 million from a prior $80 million - $100 million target. For the third quarter, the company guided revenue to approximately $170 million, representing about 35% year-over-year growth.

Key operational metrics highlighted by the company included an expanded HPC pipeline of roughly $850 million on an annualized basis and test cell utilization at 80%. Management said recurring revenue accounted for 53% of total sales, a figure supported by higher utilization and an expanding pipeline. The company also pointed to wins for its Eclipse platform with leading chip manufacturers for AI processor testing as evidence of its role in enabling HPC test capacity.

Analyst reaction included a price target lift from Needham, which increased its target on the stock to $65 from $54 while maintaining a Buy rating, citing the strong quarterly performance and the improved outlook for HPC demand.

The broader market provided a constructive backdrop to the rally. On the session, the NASDAQ gained 1.3%, the S&P 500 rose 0.5%, and the Dow Jones advanced 0.7%, reflecting ongoing investor appetite for technology and AI-adjacent names. Cohu's results arrived amid continued focus on semiconductor equipment spending tied to artificial intelligence infrastructure, a theme cited by management in explaining the company's positioning.


Taken together, the combination of a decisive earnings beat, materially upgraded HPC guidance, a bullish analyst price-target revision, and supportive market conditions created the environment for the pronounced pre-market move. Investors appeared to reprice Cohu's growth trajectory heading into the second half of 2026 based on the new financial targets and pipeline commentary.

Risks

  • Cohu's outlook and valuation are tied to continued demand for semiconductor equipment related to AI infrastructure - a shift in that spending theme could affect the company's growth trajectory and the stock - this impacts the semiconductor equipment and broader technology sectors.
  • The company's recurring revenue proportion and growth are linked to test cell utilization levels; any decline in utilization could reduce recurring revenue contributions and weigh on results - this affects operations within semiconductor test services and equipment.
  • Market sentiment toward technology and AI-adjacent names provided supportive conditions for the stock - a reversal in that macro environment could reduce investor appetite and pressure share performance, impacting technology and broader equity markets.

More from Stock Markets

Treasury Anti-Money Laundering Director Andrea Gacki to Join Citigroup as Global Head of Sanctions Jul 31, 2026 Evercore ISI Keeps Apple as Top Pick in IT Hardware & Networking After June Quarter Jul 31, 2026 AI-Focused Hedge Fund Suffered 67% Drop in July After Concentrated AI Losses Jul 31, 2026 Fitch Lowers Senior Secured Rating on Aston Martin Capital Amid New Loan Structure Jul 31, 2026 Warsaw market closes higher as WIG30 hits fresh record; energy and media stocks lead gains Jul 31, 2026